Resultados de Procura por Autor

1

Enhanced Sensitivity of G1 Arrested Human Cancer Cells Suggests a Novel Therapeutic Strategy Using a Combination of Simvastatin and TRAIL por Zhaoyu Jin, David T. Dicker, Wafik S. El‐Deiry

Publicado 2002

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
2

Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner por Varun V. Prabhu, Joshua E. Allen, David T. Dicker, Wafik S. El‐Deiry

Publicado 2015

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
3

Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-... por Zhaoyu Jin, E. Robert McDonald, David T. Dicker, Wafik S. El‐Deiry

Publicado 2004

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
4

The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia por Jun Zhang, Lanlan Zhou, Shuai Zhao, David T. Dicker, Wafik S. El‐Deiry

Publicado 2017

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
5

Circulating tumor cells: silent predictors of metastasis por Lanlan Zhou, David T. Dicker, Elizabeth Matthew, Wafik S. El‐Deiry, R. Katherine Alpaugh

Publicado 2017

Ligazón do recurso Ligazón do recurso
Pré-impressão

Engadir a favoritos

Gardado en:
6

CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth por Noel A. Warfel, Nathan G. Dolloff, David T. Dicker, Jozef Malysz, Wafik S. El‐Deiry

Publicado 2013

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
7

Silencing of the Novel p53 Target Gene Snk/Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells por Timothy F. Burns, Peiwen Fei, Kimberly A. Scata, David T. Dicker, Wafik S. El‐Deiry

Publicado 2003

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
8

The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis por Rishu Takimoto, Wenge Wang, David T. Dicker, Farzan Rastinejad, Joseph P. Lyssikatos, Wafik S. El‐Deiry

Publicado 2002

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
9

BRCA1 Transcriptionally Regulates Damaged DNA Binding Protein (DDB2) In the DNA Repair Response Following UV-Irradiation por Rishu Takimoto, Timothy K. MacLachlan, David T. Dicker, Yoshiro Niitsu, Toshio Mori, Wafik S. El‐Deiry

Publicado 2002

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
10

Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity por M. Ricci, Zhaoyu Jin, Michael Dews, Duonan Yu, Andrei Thomas‐Tikhonenko, David T. Dicker, Wafik S. El‐Deiry

Publicado 2004

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
11

Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab por Lori S. Hart, Nathan G. Dolloff, David T. Dicker, Constantinos Koumenis, James G. Christensen, Adda Grimberg, Wafik S. El‐Deiry

Publicado 2011

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
12

miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells por Amriti R. Lulla, Michael Slifker, Yan Zhou, Avital Lev, Margret B. Einarson, David T. Dicker, Wafik S. El‐Deiry

Publicado 2017

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
13

Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases por Akshal Patel, Joshua E. Allen, David T. Dicker, Kristi L. Peters, Jonas M. Sheehan, Michael Glantz, Wafik S. El‐Deiry

Publicado 2011

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
14

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway por Joshua E. Allen, Gabriel Krigsfeld, Luv Patel, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry

Publicado 2015

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
15

Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation por Varun V. Prabhu, Bo Hong, Joshua E. Allen, Shengliang Zhang, Amriti R. Lulla, David T. Dicker, Wafik S. El‐Deiry

Publicado 2016

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
16

TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death por Kageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, Jing Xu, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry

Publicado 2008

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
17

The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions por Elizabeth Matthew, Lori S. Hart, Aristotelis Astrinidis, Arunasalam Navaraj, Nathan G. Dolloff, David T. Dicker, Elizabeth P. Henske, Wafik S. El‐Deiry

Publicado 2009

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
18

Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells por Seok‐Hyun Kim, Kunhong Kim, Jae Kwagh, David T. Dicker, Meenhard Herlyn, Anil K. Rustgi, Youhai Chen, Wafik S. El‐Deiry

Publicado 2004

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
19

Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53 por Bo Hong, Varun V. Prabhu, Shengliang Zhang, A. Pieter J. van den Heuvel, David T. Dicker, Levy Kopelovich, Wafik S. El‐Deiry

Publicado 2013

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
20

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis por Junaid Abdulghani, Joshua E. Allen, David T. Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D. Smith, Robin Humphreys, Wafik S. El‐Deiry

Publicado 2013

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:

Enhanced Sensitivity of G1 Arrested Human Cancer Cells Suggests a Novel Therapeutic Strategy Using a Combination of Simvastatin and TRAIL por Zhaoyu Jin, David T. Dicker, Wafik S. El‐Deiry

Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner por Varun V. Prabhu, Joshua E. Allen, David T. Dicker, Wafik S. El‐Deiry

Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-... por Zhaoyu Jin, E. Robert McDonald, David T. Dicker, Wafik S. El‐Deiry

The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia por Jun Zhang, Lanlan Zhou, Shuai Zhao, David T. Dicker, Wafik S. El‐Deiry

Circulating tumor cells: silent predictors of metastasis por Lanlan Zhou, David T. Dicker, Elizabeth Matthew, Wafik S. El‐Deiry, R. Katherine Alpaugh

CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth por Noel A. Warfel, Nathan G. Dolloff, David T. Dicker, Jozef Malysz, Wafik S. El‐Deiry

Silencing of the Novel p53 Target Gene <i>Snk</i>/<i>Plk2</i> Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells por Timothy F. Burns, Peiwen Fei, Kimberly A. Scata, David T. Dicker, Wafik S. El‐Deiry

The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis por Rishu Takimoto, Wenge Wang, David T. Dicker, Farzan Rastinejad, Joseph P. Lyssikatos, Wafik S. El‐Deiry

BRCA1 Transcriptionally Regulates Damaged DNA Binding Protein (DDB2) In the DNA Repair Response Following UV-Irradiation por Rishu Takimoto, Timothy K. MacLachlan, David T. Dicker, Yoshiro Niitsu, Toshio Mori, Wafik S. El‐Deiry

Direct Repression of <i>FLIP</i> Expression by c-myc Is a Major Determinant of TRAIL Sensitivity por M. Ricci, Zhaoyu Jin, Michael Dews, Duonan Yu, Andrei Thomas‐Tikhonenko, David T. Dicker, Wafik S. El‐Deiry

Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab por Lori S. Hart, Nathan G. Dolloff, David T. Dicker, Constantinos Koumenis, James G. Christensen, Adda Grimberg, Wafik S. El‐Deiry

miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells por Amriti R. Lulla, Michael Slifker, Yan Zhou, Avital Lev, Margret B. Einarson, David T. Dicker, Wafik S. El‐Deiry

Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases por Akshal Patel, Joshua E. Allen, David T. Dicker, Kristi L. Peters, Jonas M. Sheehan, Michael Glantz, Wafik S. El‐Deiry

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway por Joshua E. Allen, Gabriel Krigsfeld, Luv Patel, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry

Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation por Varun V. Prabhu, Bo Hong, Joshua E. Allen, Shengliang Zhang, Amriti R. Lulla, David T. Dicker, Wafik S. El‐Deiry

TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death por Kageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, Jing Xu, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry

The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions por Elizabeth Matthew, Lori S. Hart, Aristotelis Astrinidis, Arunasalam Navaraj, Nathan G. Dolloff, David T. Dicker, Elizabeth P. Henske, Wafik S. El‐Deiry

Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells por Seok‐Hyun Kim, Kunhong Kim, Jae Kwagh, David T. Dicker, Meenhard Herlyn, Anil K. Rustgi, Youhai Chen, Wafik S. El‐Deiry

Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53 por Bo Hong, Varun V. Prabhu, Shengliang Zhang, A. Pieter J. van den Heuvel, David T. Dicker, Levy Kopelovich, Wafik S. El‐Deiry

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis por Junaid Abdulghani, Joshua E. Allen, David T. Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D. Smith, Robin Humphreys, Wafik S. El‐Deiry

Resultados de procura - David T. Dicker

Enhanced Sensitivity of G1 Arrested Human Cancer Cells Suggests a Novel Therapeutic Strategy Using a Combination of Simvastatin and TRAIL por Zhaoyu Jin, David T. Dicker, Wafik S. El‐Deiry

Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem–like Cells in an Akt/Foxo3a/TRAIL–Dependent Manner por Varun V. Prabhu, Joshua E. Allen, David T. Dicker, Wafik S. El‐Deiry

Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-... por Zhaoyu Jin, E. Robert McDonald, David T. Dicker, Wafik S. El‐Deiry

The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia por Jun Zhang, Lanlan Zhou, Shuai Zhao, David T. Dicker, Wafik S. El‐Deiry

Circulating tumor cells: silent predictors of metastasis por Lanlan Zhou, David T. Dicker, Elizabeth Matthew, Wafik S. El‐Deiry, R. Katherine Alpaugh

CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth por Noel A. Warfel, Nathan G. Dolloff, David T. Dicker, Jozef Malysz, Wafik S. El‐Deiry

Silencing of the Novel p53 Target Gene <i>Snk</i>/<i>Plk2</i> Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells por Timothy F. Burns, Peiwen Fei, Kimberly A. Scata, David T. Dicker, Wafik S. El‐Deiry

The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis por Rishu Takimoto, Wenge Wang, David T. Dicker, Farzan Rastinejad, Joseph P. Lyssikatos, Wafik S. El‐Deiry

BRCA1 Transcriptionally Regulates Damaged DNA Binding Protein (DDB2) In the DNA Repair Response Following UV-Irradiation por Rishu Takimoto, Timothy K. MacLachlan, David T. Dicker, Yoshiro Niitsu, Toshio Mori, Wafik S. El‐Deiry

Direct Repression of <i>FLIP</i> Expression by c-myc Is a Major Determinant of TRAIL Sensitivity por M. Ricci, Zhaoyu Jin, Michael Dews, Duonan Yu, Andrei Thomas‐Tikhonenko, David T. Dicker, Wafik S. El‐Deiry

Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab por Lori S. Hart, Nathan G. Dolloff, David T. Dicker, Constantinos Koumenis, James G. Christensen, Adda Grimberg, Wafik S. El‐Deiry

miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells por Amriti R. Lulla, Michael Slifker, Yan Zhou, Avital Lev, Margret B. Einarson, David T. Dicker, Wafik S. El‐Deiry

Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases por Akshal Patel, Joshua E. Allen, David T. Dicker, Kristi L. Peters, Jonas M. Sheehan, Michael Glantz, Wafik S. El‐Deiry

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway por Joshua E. Allen, Gabriel Krigsfeld, Luv Patel, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry

Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation por Varun V. Prabhu, Bo Hong, Joshua E. Allen, Shengliang Zhang, Amriti R. Lulla, David T. Dicker, Wafik S. El‐Deiry

TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death por Kageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, Jing Xu, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry

The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions por Elizabeth Matthew, Lori S. Hart, Aristotelis Astrinidis, Arunasalam Navaraj, Nathan G. Dolloff, David T. Dicker, Elizabeth P. Henske, Wafik S. El‐Deiry

Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells por Seok‐Hyun Kim, Kunhong Kim, Jae Kwagh, David T. Dicker, Meenhard Herlyn, Anil K. Rustgi, Youhai Chen, Wafik S. El‐Deiry

Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53 por Bo Hong, Varun V. Prabhu, Shengliang Zhang, A. Pieter J. van den Heuvel, David T. Dicker, Levy Kopelovich, Wafik S. El‐Deiry

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis por Junaid Abdulghani, Joshua E. Allen, David T. Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D. Smith, Robin Humphreys, Wafik S. El‐Deiry

Ferramentas de procura:

Materias Relacionadas